Plasma nucleic acid analysis by massively parallel sequencing: Pathological insights and diagnostic implications

Journal of Pathology

Volumn 225, Issue 3, 2011, Pages 318-323

  Dennis Lo, Ym ^a,b   Chiu, Rossa Wk ^a,b  

^a Li Ka Shing Institute of Health Sciences   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

circulating DNA; diagnosis; next generation sequencing

Indexed keywords

DNA; HLA ANTIGEN;

ANEUPLOIDY; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MATERNAL PLASMA; NUCLEIC ACID ANALYSIS; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SEQUENCING BATCH REACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE INJURY; TRANSPLANTATION;

DNA; DNA, NEOPLASM; GRAFT REJECTION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NEOPLASMS; ORGAN TRANSPLANTATION; POSTOPERATIVE CARE; SEQUENCE ANALYSIS, DNA;

EID: 80054742079     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2960     Document Type: Review

References (48)

1. Mandel P, Métais P,. Les acides nucléiques du plasma sanguin chez l'homme. C R Acad Sci Paris 1948; 142: 241-243.
2. Tsang JC, Lo YMD,. Circulating nucleic acids in plasma/serum. Pathology 2007; 39: 197-207. (Pubitemid 46439650)
3. Lo YMD, Corbetta N, Chamberlain PF, et al., Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-487. (Pubitemid 27343304)
4. Nawroz H, Koch W, Anker P, et al., Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 1996; 2: 1035-1037. (Pubitemid 26306845)
5. Chen XQ, Stroun M, Magnenat JL, et al., Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 1996; 2: 1033-1035. (Pubitemid 26306844)
6. Lo YMD, Tein MSC, Pang CCP, et al., Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients. Lancet 1998; 351: 1329-1330. (Pubitemid 28195915)
7. Lo YMD, Rainer TH, Chan LY, et al., Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000; 46: 319-323. (Pubitemid 30152256)
8. Schuster SC,. Next-generation sequencing transforms today's biology. Nat Methods 2008; 5: 16-18.
9. Lo YMD, Tein MS, Lau TK, et al., Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998; 62: 768-775. (Pubitemid 28194317)
10. Costa JM, Benachi A, Gautier E,. New strategy for prenatal diagnosis of X-linked disorders. N Engl J Med 2002; 346: 1502. (Pubitemid 34755726)
11. Lo YMD, Hjelm NM, Fidler C, et al., Prenatal diagnosis of fetal rhd status by molecular analysis of maternal plasma. N Engl J Med 1998; 339: 1734-1738. (Pubitemid 28555431)
12. Finning K, Martin P, Summers J, et al., Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD-negative pregnant women: prospective feasibility study. Br Med J 2008; 336: 816-818. (Pubitemid 351548224)
13. Lo YMD, Lun FM, Chan KC, et al., Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA 2007; 104: 13116-13121. (Pubitemid 351737602)
14. Vogelstein B, Kinzler KW,., Digital PCR,. Proc Natl Acad Sci USA 1999; 96: 9236-9241.
15. Chiu RWK, Chan KCA, Gao Y, et al., Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 2008; 105: 20458-20463.
16. Fan HC, Blumenfeld YJ, Chitkara U, et al., Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 2008; 105: 16266-16271.
17. Chiu RWK, Akolekar R, Zheng YW, et al., Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large-scale validity study. Br Med J 2011; 342: c7401.
18. Ehrich M, Deciu C, Zwiefelhofer T, et al., Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011; 204: 205 e1-11.
19. Chiu RWK, Sun H, Akolekar R, et al., Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin Chem 2010; 56: 459-463.
20. Fan HC, Quake SR,. Sensitivity of noninvasive prenatal detection of fetal aneuploidy from maternal plasma using shotgun sequencing is limited only by counting statistics. PLoS ONE 2010; 5: e10439.
21. Sehnert AJ, Rhees B, Comstock D, et al., Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011; (in press).
22. Lo YMD, Chan KCA, Sun H, et al., Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010; 2: 61ra91.
23. Liao GJ, Lun FM, Zheng YW, et al., Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles. Clin Chem 2011; 57: 92-101.
24. Fan HC, Wang J, Potanina A, et al., Whole-genome molecular haplotyping of single cells. Nat Biotechnol 2011; 29: 51-57.
25. Kitzman JO, Mackenzie AP, Adey A, et al., Haplotype-resolved genome sequencing of a Gujarati Indian individual. Nat Biotechnol 2011; 29: 59-63.
26. Greely HT,. Get ready for the flood of fetal gene screening. Nature 2011; 469: 289-291.
27. de Jong A, Dondorp WJ, de Die-Smulders CE, et al., Non-invasive prenatal testing: ethical issues explored. Eur J Hum Genet 2010; 18: 272-277.
28. Chan KCA, Zhang J, Hui AB, et al., Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 2004; 50: 88-92. (Pubitemid 38125703)
29. Lewin B,. Nucleosomes: Gene IX. Sudbury: Jones and Bartlett, 2008; 757-95.
30. Leon SA, Shapiro B, Sklaroff DM, et al., Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977; 37: 646-650. (Pubitemid 8051621)
31. Beck J, Umovitz HB, Riggert J, et al., Profile of the circulating DNA in apparently healthy individuals. Clin Chem 2009; 55: 730-738.
32. Stroun M, Lyautey J, Lederrey C, et al., Alu repeat sequences are present in increased proportions compared to a unique gene in plasma/serum DNA: evidence for a preferential release from viable cells? Ann NY Acad Sci 2001; 945: 258-264. (Pubitemid 33022462)
33. Beck J, Urnovitz HB, Mitchell WM, et al., Next generation sequencing of serum circulating nucleic acids from patients with invasive ductal breast cancer reveals differences to healthy and nonmalignant controls. Mol Cancer Res 2010; 8: 335-342.
34. Leary RJ, Kinde I, Diehl F, et al., Development of personalized tumor biomarker using massively parallel sequencing. Sci Transl Med 2010; 2: 20ra14.
35. McBride DJ, Orpana AK, Sotiriou C, et al., Use of cancer-specific genomic rearrangements to quantify disease burden in plasma from patients with solid tumors. Genes Chromosomes Cancer 2010; 49: 1062-1069.
36. Korshunova Y, Maloney RK, Lakey N, et al., Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA. Genome Res 2008; 18: 19-29.
37. Lui YYN, Woo KS, Wang AYM, et al., Origin of plasma cell-free DNA after solid organ transplantation. Clin Chem 2003; 49: 495-496. (Pubitemid 36250211)
38. Lui YY, Chik KW, Chiu RWK, et al., Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 2002; 48: 421-427. (Pubitemid 34174575)
39. Gadi VK, Nelson JL, Boespflug ND, et al., Soluble donor DNA concentrations in recipient serum correlate with pancreas-kidney rejection. Clin Chem 2006; 52: 379-382.
40. Moreira VG, Garcia BP, Martin JMD, et al., Cell-free DNA as a noninvasive acute rejection marker in renal transplantation. Clin Chem 2009; 55: 1958-1966.
41. Martins PN, Mashreghi MF, Reutzel-Selke A, et al., Quantification of donor-derived DNA in serum: a new approach of acute rejection diagnosis in a rat kidney transplantation model. Transpl Proc 2005; 37: 87-88. (Pubitemid 40459698)
42. Snyder TM, Khush KK, Valantine HA, et al., Universal noninvasive detection of solid organ transplant rejection. Proc Natl Acad Sci USA 2011; 108: 6229-6234.
43. Rainer TH, Lam NY, Man CY, et al., Plasma β-globin DNA as a prognostic marker in chest pain patients. Clin Chim Acta 2006; 368: 110-113. (Pubitemid 43776038)
44. Rainer TH, Wong LK, Lam W, et al., Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 2003; 49: 562-569. (Pubitemid 36379520)
45. Saukkonen K, Lakkisto P, Pettila V, et al., Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin Chem 2008; 54: 1000-1007. (Pubitemid 351793406)
46. Beck J, Urnovitz HB, Saresella M, et al., Serum DNA motifs predict disease and clinical status in multiple sclerosis. J Mol Diagn 2010; 12: 312-319.
47. Liggett T, Melnikov A, Tilwalli S, et al., Methylation patterns of cell-free plasma DNA in relapsing-remitting multiple sclerosis. J Neurol Sci 2010; 290: 16-21.
48. Gordon PM, Schutz E, Beck J, et al., Disease-specific motifs can be identified in circulating nucleic acids from live elk and cattle infected with transmissible spongiform encephalopathies. Nucleic Acids Res 2009; 37: 550-556.